Home » Clinical development » The use of CARBALIVE in the treatment of cholestatic liver disease
The use of CARBALIVE in the treatment of cholestatic liver disease

Research area:

Rare disease

Disease:

Cholestatic liver disease

Intervention:

Device

Phase:

Phase II

Public registration details (where available)

ISRCTN16819837